Cathepsin B-Responsive Liposomes for Controlled Anticancer Drug Delivery in Hep G2 Cells
In recent decades, several types of anticancer drugs that inhibit cancer cell growth and cause cell death have been developed for chemotherapeutic application. However, these agents are usually associated with side effects resulting from nonspecific delivery, which may induce cytotoxicity in healthy...
Saved in:
Main Authors: | Seulgi Lee (Author), Su Jeong Song (Author), Jeil Lee (Author), Tai Hwan Ha (Author), Joon Sig Choi (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanoemulsion Composed of α-Tocopherol Succinate and Dequalinium Shows Mitochondria-Targeting and Anticancer Effects
by: Le Thi Thuy, et al.
Published: (2023) -
Enzyme-Responsive Amphiphilic Peptide Nanoparticles for Biocompatible and Efficient Drug Delivery
by: Su Jeong Song, et al.
Published: (2022) -
Development of a Peptide-Based Nano-Sized Cathepsin B Inhibitor for Anticancer Therapy
by: So-Hyeon Park, et al.
Published: (2023) -
Identification of matrix metalloproteinases secreted by human hepatocarcinoma HepG2 cells
by: Young Jae Lee, et al.
Published: (2022) -
Anticancer and apoptosis-inducing effects of Moringa concanensis using hepG2 cell lines
by: V. Balamurugan, et al.
Published: (2014)